Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Lacosamide fda approval date?

See the DrugPatentWatch profile for Lacosamide

Lacosamide (brand Vimpat) was approved by the FDA on March 26, 2008, as an adjunctive therapy for adults with partial-onset seizures. It later received additional indications and formulation approvals. If you’d like, I can share the official FDA press release or provide more details on later approvals.



Other Questions About Lacosamide :

alternative lacosamide\ Is lacosamide safe for elderly patients? How often should bp be monitored during lacosamide treatment? Lacosamide serum levels? Is lacosamide more effective than other options? Lacosamide names? What factors determine the need for lacosamide dosage adjustment?